thanks Vmk
So it's the point that costs have plateaued/reducing rather than cashflow breakeven.
Didn't previously consider that as an inflection point, but I guess it would be if they can continue growing revenues/ARR at a similar rate to the past (i.e. they can demonstrate operating leverage for the business and the SaaS model)
- Forums
- ASX - By Stock
- LVT
- Ann: 1st Half FY19 Results Announcement
Ann: 1st Half FY19 Results Announcement, page-72
-
- There are more pages in this discussion • 50 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add LVT (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online